Skip to main content
Log in

Changes of molecular forms of atrial natriuretic peptide after treatment for congestive heart failure

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

In the present study, an attempt was made to clarify whether ANP molecular forms in the plasma of severe congestive heart failure patients differ from those in healthy persons and whether ANP molecular forms in the plasma of the patients were changed by successful treatment of cardiac disease.

Twenty patients with congestive heart failure were treated at Kitasato University Hospital. They were classified as class III or IV by New York Heart Association criteria at the time of admission. Plasma ANP concentrations decreased after treatment from 356 ± 58.2 to 72.3 ± 14.8 pg/ml. The gel permeation chromatograms from the plasma of healthy persons showed low, or low and high molecular weight ANP peaks which correspond to the elution positions of authentic α-ANP or ribonuclease A (mol.wt., 13.7 kdalton). In patients with severe congestive heart failure at a severe stage, middle molecular weight ANP consisted with the elution position of authenticβ-ANP was particularly noted in addition of low and high molecular weight ANP peaks. This middle molecular weight peak disappears in most of cases by successful treatment. Molecular forms in the plasma obtained from the coronary sinus and the inferior or superior vena cava were essentially the same.

These results indicate that the middle molecular weight ANP supposed asβ-ANP may particularly be secreted in severe congestive heart failure patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

ANP:

atrial natriuretic peptide

NYHA criteria:

New York Heart Association criteria

SIADH:

Syndrome of inappropriate secretion of ADH

References

  1. Arendt RM, Gerbes AL, Ritter D, Stnagl E (1986) Molecular weight heterogeneity of plasma-ANF in cardiovascular disease. Klin Wochenschr 64: (Suppl VI):97–102

    Google Scholar 

  2. Eisenhauer T, Talartschik J, Scheler F (1986) Detection of fluid overload by plasma concentration of human atrial natriuretic peptide (h-ANP) in patients with renal failure. Klin Wochenschr 64:68–72

    Google Scholar 

  3. Kangawa K, Matsuo H (1984) Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP). Biochem Biophys Res Comm 118:131–139

    Google Scholar 

  4. Katoh Y, Kurosawa T, Takeda S, Sakamoto H, Marumo F, Kikawada R (1986) Atrial natriuretic peptide levels in treated congestive heart failure. Lancet I:851

    Google Scholar 

  5. Kurokawa S, Katoh Y, Sugiyama T, Kurosawa T, Takeda S, Sakamoto H, Marumo F, Kikawada R (1987) Correlation of decreased plasma atrial natriuretic peptide level with left atrial diameter in chronic hemodialysis. Am J Cardiol 60:1135

    Google Scholar 

  6. Marumo F, Sakamoto H, Ando K, Ishigami T, Kawakami M (1986) A highly sensitive radioimmunoassay of atrial natriuretic peptide (ANP) in human plasma and urine. Biochem Biophys Res Comm 137:231–236

    Google Scholar 

  7. Misono KS, Fukumi H, Grammer RT, Inagami T (1984) Rat atrial natriuretic factor: Complete amino acid sequence and disulfide linkage essential for biological activity. Biochem Biophys Res Comm 119:524–529

    Google Scholar 

  8. Miyata A, Toshimori T, Hashiguchi T, Kangawa K, Matsuo H (1987) Molecular forms of atrial natriuretic polypeptides circulating in human plasma. Biochem Biophys Res Comm 142:461–467

    Google Scholar 

  9. Nakaoka H, Imataka K, Amano J, Ishibashi M, Yamaji T (1985) Plasma levels of atrial natriuretic factor in patients with congestive heart failure. N Engl J Med 313:892–893

    Google Scholar 

  10. Petzl DH, Hartter E, Osterode W, Böhm H, Woloszcuk W, Schuster E (1986) Plasma atrial natriuretic peptide concentrations in the recovery period of myocardial infarction in arterial and venous blood samples. Horm Metabol Res 18:501–502

    Google Scholar 

  11. Sagnella G, Markandu ND, Shore AC, MacGregor GA (1986) Raised circulating levels of atrial natriuretic peptides in essential hypertension. Lancet I:179–181

    Google Scholar 

  12. Sakamoto H, Inoue K, Marumo F (1986) High plasma atrial natriuretic peptide independent of sodium balance in SIADH. JAMA 256:1293–1294

    Google Scholar 

  13. Sugawara A, Nakao K, Morii N, Yamada T, Itoh H, Shiono S, Saito Y, Mukoyama M, Arai H, Nishimura K, Obata K, Yasue H, Ban T, Imura H (1988) Augmented synthesis of α-human atrial natriuretic polypeptide in human failing hearts. Biochem Biophys Res Comm 150:60–67

    Google Scholar 

  14. Yamada K, Tajima K, Moriwaki K, Tarui S, Kangawa K, Matsuo H (1986) Atrial natriuretic peptide in Bartter's syndrome. Lancet I:273

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marumo, F., Kurosawa, T., Takeda, S. et al. Changes of molecular forms of atrial natriuretic peptide after treatment for congestive heart failure. Klin Wochenschr 66, 675–681 (1988). https://doi.org/10.1007/BF01726925

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01726925

Key words

Navigation